Hepatitis C virus core antigen testing in liver and kidney transplant recipients

Journal of Viral Hepatitis

Volumn 21, Issue 11, 2014, Pages 769-779

  Heidrich, B ^a   Pischke, S ^a   Helfritz, F A ^a   Mederacke, I ^a   Kirschner, J ^a   Schneider, J ^a   Raupach, R ^a   Jackel E ^a   Barg Hock, H ^a   Lehner, F ^a   Klempnauer, J ^a   Von Hahn, T ^a   Cornberg, M ^a   Manns, M P ^a   Ciesek, S ^a   Wedemeyer, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

hepatitis C; hepatitis C virus; hepatitis C virus core Antigen; hepatitis C virus coreAg; kidney transplantation; liver transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS RNA; CORE PROTEIN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ADD ON THERAPY; ADULT; ANTIVIRAL THERAPY; ARTICLE; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C RAPID TEST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; AGED; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; IMMUNOASSAY; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS C; HUMANS; IMMUNOASSAY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; TRANSPLANT RECIPIENTS; VIRAL CORE PROTEINS; VIRAL LOAD; YOUNG ADULT;

EID: 84908051690     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12204     Document Type: Article

References (35)

1. Lavanchy D,. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17 (2): 107-115.
2. Negro F, Alberti A,. The global health burden of hepatitis C virus infection. Liver Int 2011; 31 (Suppl 2): 1-3.
3. Ciesek S, Wedemeyer H,. Immunosuppression, liver injury and post-transplant HCV recurrence. J Viral Hepat 2012; 19 (1): 1-8.
4. Rubin A, Aguilera V, Berenguer M,. Liver transplantation and hepatitis C. Clin Res Hepatol Gastroenterol 2011; 35 (12): 805-812.
5. Dominguez-Gil B, Morales JM,. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22 (12): 1117-1131.
6. Gane EJ,. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14 (Suppl 2): S36-S44.
7. Berenguer M, Aguilera V, Rubin A, Ortiz C, Jimenez M, Prieto M,. Comparison of two non-contemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy. J Hepatol 2012; 56 (6): 1310-1316.
8. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM,. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012; 56 (Suppl 1): S88-S100.
9. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB,. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54 (4): 1433-1444.
10. Park YN, Boros P, Zhang DY, Sheiner P, Kim-Schluger L, Thung SN,. Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C. Arch Pathol Lab Med 2000; 124 (11): 1623-1627.
11. Satapathy SK, Sclair S, Fiel MI, Del Rio Martin J, Schiano T,. Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res 2011; 41 (4): 328-339.
12. Haque M, Hashim A, Greanya ED, Steinbrecher UP, Erb SR, Yoshida EM,. Spontaneous clearance of hepatitis C infection post-liver transplant: a rare but real phenomenon? A case report and review of the literature. Ann Hepatol 2010; 9 (2): 202-206.
13. Suneetha PV, Mederacke I, Heim A, et al,. Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue? Liver Transpl 2008; 14 (8): 1225-1227.
14. Bhagat V, Foont JA, Schiff ER, Regev A,. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Liver Transpl 2008; 14 (1): 92-95.
15. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011; 55 (2): 245-264.
16. Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49 (4): 1335-1374.
17. Sarrazin C, Berg T, Ross RS, et al,. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol 2010; 48 (2): 289-351.
18. Scott JD, Gretch DR,. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA. 2007; 297 (7): 724-732.
19. Al Olaby RR, Azzazy HM,. Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications. Expert Rev Mol Diagn 2011; 11 (1): 53-64.
20. Chevaliez S, Pawlotsky JM,. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C. J Viral Hepat 2007; 14 (Suppl 1): 77-81.
21. Morota K, Fujinami R, Kinukawa H, et al,. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods 2009; 157 (1): 8-14.
22. Ross RS, Viazov S, Salloum S, Hilgard P, Gerken G, Roggendorf M,. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J Clin Microbiol 2010; 48 (4): 1161-1168.
23. Mederacke I, Wedemeyer H, Ciesek S, et al,. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol 2009; 46 (3): 210-215.
24. Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J,. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010; 48 (1): 18-21.
25. Park Y, Lee JH, Kim BS, Kim do Y, Han KH, Kim HS,. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol. 2010; 48 (6): 2253-2256.
26. Mederacke I, Potthoff A, Meyer-Olson D, et al,. HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis. J Clin Virol 2012; 53 (2): 110-115.
27. Garcia-Retortillo M, Forns X, Feliu A, et al,. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002; 35 (3): 680-687.
28. Powers KA, Ribeiro RM, Patel K, et al,. Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl 2006; 12 (2): 207-216.
29. Ciesek S, Steinmann E, Wedemeyer H, et al,. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology 2009; 50 (5): 1638-1645.
30. von Hahn T, Ciesek S, Manns MP,. Arrest all accessories-inhibition of hepatitis C virus by compounds that target host factors. Discov Med 2011; 12 (64): 237-244.
31. Irish WD, Arcona S, Bowers D, Trotter JF,. Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. Am J Transplant 2011; 11 (8): 1676-1685.
32. Berenguer M,. Viral hepatitis: ciclosporin versus tacrolimus for HCV transplant recipients. Nat Rev Gastroenterol Hepatol 2011; 8 (8): 422-424.
33. Fafi-Kremer S, Fofana I, Soulier E, et al,. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J Exp Med 2010; 207 (9): 2019-2031.
34. Gane EJ, Naoumov NV, Qian KP, et al,. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110 (1): 167-177.
35. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, et al,. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32 (5): 1125-1130.